NASDAQ:AMGN - Amgen Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$192.80 -1.12 (-0.58 %)
(As of 07/18/2018 04:00 PM ET)
Previous Close$193.92
Today's Range$192.05 - $194.00
52-Week Range$163.31 - $201.23
Volume2.15 million shs
Average Volume4.04 million shs
Market Capitalization$128.95 billion
P/E Ratio15.40
Dividend Yield2.71%
Beta1.38

Analyst Ratings

Amgen (NASDAQ:AMGN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
20 Wall Street analysts have issued ratings and price targets for Amgen in the last 12 months. Their average twelve-month price target is $196.1771, suggesting that the stock has a possible upside of 1.75%. The high price target for AMGN is $220.00 and the low price target for AMGN is $174.00. There are currently 10 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldHold
Consensus Rating Score: 2.502.482.432.43
Ratings Breakdown: 0 Sell Rating(s)
10 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
11 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
13 Hold Rating(s)
10 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
12 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $196.1771$193.6672$190.8505$190.00
Price Target Upside: 1.75% upside5.00% upside11.47% upside5.64% upside

Amgen (NASDAQ:AMGN) Consensus Price Target History

Price Target History for Amgen (NASDAQ:AMGN)

Amgen (NASDAQ:AMGN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/16/2018Jefferies Financial GroupReiterated RatingBuy$200.00LowView Rating Details
7/13/2018Morgan StanleyBoost Price TargetBuy$200.00 ➝ $210.00LowView Rating Details
6/22/2018MizuhoReiterated RatingBuy$200.00LowView Rating Details
6/8/2018CannReiterated RatingBuyLowView Rating Details
4/25/2018Royal Bank of CanadaLower Price TargetSector Perform$183.00HighView Rating Details
4/24/2018CowenReiterated RatingBuy$204.00MediumView Rating Details
4/5/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$190.00 ➝ $180.00LowView Rating Details
2/5/2018Atlantic SecuritiesDowngradeOverweight ➝ Neutral$187.01HighView Rating Details
2/4/2018JPMorgan Chase & Co.Reiterated RatingHold$191.00HighView Rating Details
2/2/2018Leerink SwannReiterated RatingMarket PerformHighView Rating Details
2/2/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$191.00 ➝ $194.00LowView Rating Details
2/2/2018BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$192.00 ➝ $202.00MediumView Rating Details
2/2/2018Piper Jaffray CompaniesLower Price TargetOverweight ➝ Overweight$194.00 ➝ $190.00MediumView Rating Details
1/30/2018OppenheimerReiterated RatingBuy$205.00 ➝ $205.00LowView Rating Details
1/23/2018ArgusUpgradeHold ➝ Buy$192.33 ➝ $220.00LowView Rating Details
12/18/2017CitigroupDowngradeNeutralLowView Rating Details
12/15/2017Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyHighView Rating Details
10/5/2017Bank of AmericaBoost Price TargetBuy$210.00N/AView Rating Details
7/26/2017UBS GroupSet Price TargetHold$175.00 ➝ $180.00HighView Rating Details
7/26/2017Deutsche BankReiterated RatingHold$172.00 ➝ $174.00LowView Rating Details
6/26/2017William BlairReiterated RatingMarket PerformLowView Rating Details
6/8/2017Sanford C. BernsteinSet Price TargetHold$164.00MediumView Rating Details
4/28/2017Robert W. BairdReiterated RatingNeutral$165.00LowView Rating Details
12/13/2016Chardan CapitalUpgradeSell ➝ NeutralN/AView Rating Details
8/26/2016GabelliInitiated CoverageHoldN/AView Rating Details
(Data available from 7/18/2016 forward)
This page was last updated on 7/18/2018 by MarketBeat.com Staff

Featured Article: Short Selling

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.